Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar/Apr;24(2):161-173.
doi: 10.1177/1203475420902047. Epub 2020 Jan 29.

Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study

Affiliations

Canadian Burden of Skin Disease From 1990 to 2017: Results From the Global Burden of Disease 2017 Study

Alanna C Bridgman et al. J Cutan Med Surg. 2020 Mar/Apr.

Abstract

Background: Skin diseases can have high morbidity that can be costly to society and individuals. To date, there has been no comprehensive assessment of the burden of skin disease in Canada.

Objectives: To evaluate the burden of 18 skin and subcutaneous diseases from 1990 to 2017 in Canada using the Global Burden of Disease (GBD) data.

Methods: The 2017 GBD study measures health loss from 359 diseases and injuries in 195 countries; we evaluated trends in population health in Canada from 1990 to 2017 using incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years (DALYs). Data are presented as rates (per 100 000), counts, or percent change with the uncertainty interval in brackets.

Results: From 1990 to 2017 for all skin diseases, DALY rates increased by 8% to 971 per 100 000 (674-1319), YLD rates increased by 8% to 897 per 100 000 (616-1235), YLL rates increased by 4% to 74 per 100 000 (53-89), and death rates increased by 18% to 5 per 100 000 (3-6). DALY rates for melanoma increased by 2% to 54 per 100 000 (39-68), for keratinocyte carcinoma by 14% to 17 per 100 000 (16-19), and for skin and subcutaneous disease by 8% to 900 per 100 000 (619-1233). The observed over expected ratios were higher for skin and subcutaneous disease (1.37) and keratinocyte carcinoma (1.17) and were lower for melanoma (0.73).

Conclusions: The burden of skin disease has increased in Canada since 1990. These results can be used to guide health policy regarding skin disease in Canada.

Keywords: disability; incidence; prevalence; skin disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. In the last 3 years, Dr Drucker served as an investigator and has received research funding from Sanofi and Regeneron and has been a consultant for Sanofi, RTI Health Solutions, Eczema Society of Canada, and Canadian Agency for Drugs and Technology in Health. He has received honoraria from Prime Inc, Spire Learning, CME Outfitters, and Eczema Society of Canada. His institution receives education grants from Sanofi.

Figures

Figure 1
Figure 1
Disability-adjusted life year (DALY) rates (per 100 000) for 18 skin diseases in Canada in 2017. BCC, basal cell carcinoma; SCC, squamous cell carcinoma.

Similar articles

Cited by

References

    1. Lim HW., Collins SAB., Resneck JS. et al. The burden of skin disease in the United States. J Am Acad Dermatol. 2017;76(5):958-972.10.1016/j.jaad.2016.12.043 - DOI - PubMed
    1. Bridgman AC., Block JK., Drucker AM. The multidimensional burden of atopic dermatitis: an update. Ann Allergy Asthma Immunol. 2018;120(6):603-606.10.1016/j.anai.2018.03.009 - DOI - PubMed
    1. Bridgman AC., Eshtiaghi P., Cresswell-Melville A., Ramien M., Drucker AM. The burden of moderate to severe atopic dermatitis in Canadian children: a cross-sectional survey. J Cutan Med Surg. 2018;22(4):443-444.10.1177/1203475418761859 - DOI - PubMed
    1. Hay RJ., Johns NE., Williams HC. et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527-1534. published Online First: 2013/10/3010.1038/jid.2013.446 - DOI - PubMed
    1. Barbarot S., Auziere S., Gadkari A. et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284-1293.10.1111/all.13401 - DOI - PubMed